Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
PJSC RusHydro: Notice of Material Transaction by RusHydro's Controlled Entity
PJSC RusHydro: Notice of Material Transaction by RusHydro's Controlled Entity
PJSC RusHydro: Notice of Material Transaction by RusHydro's Controlled Entity
Deufol SE: DEUFOL continues to focus on its core business of supply chain solutions for industrial customers
Deufol SE: DEUFOL continues to focus on its core business of supply chain solutions for industrial customers
Deufol SE: DEUFOL continues to focus on its core business of supply chain solutions for industrial customers
Superdry plc: TR-1 Notification of Major Holdings
Superdry plc: TR-1 Notification of Major Holdings
Superdry plc: TR-1 Notification of Major Holdings
Turkiye Garanti Bankasi A.S.: BRSA Consolidated Earnings Presentation dated 31 December 2021
Turkiye Garanti Bankasi A.S.: BRSA Consolidated Earnings Presentation dated 31 December 2021
Turkiye Garanti Bankasi A.S.: BRSA Consolidated Earnings Presentation dated 31 December 2021
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2022
Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2022
Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2022
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
DGAP-News: GK Software SE: GK boosts its efforts to push through the East Asian market - first branch office established in Singapore
DGAP-News: GK Software SE: GK boosts its efforts to push through the East Asian market - first branch office established in Singapore
DGAP-News: GK Software SE: GK boosts its efforts to push through the East Asian market - first branch office established in Singapore
NORNICKEL REPORTS IFRS FINANCIAL RESULTS FOR FY2021 AND HOSTS CONFERENCE CALL ON FEBRUARY 10
NORNICKEL REPORTS IFRS FINANCIAL RESULTS FOR FY2021 AND HOSTS CONFERENCE CALL ON FEBRUARY 10
NORNICKEL REPORTS IFRS FINANCIAL RESULTS FOR FY2021 AND HOSTS CONFERENCE CALL ON FEBRUARY 10
DGAP-News: Exasol's high-performance database now available as SaaS model
DGAP-News: Exasol's high-performance database now available as SaaS model
DGAP-News: Exasol's high-performance database now available as SaaS model
DGAP-News: artnet AG: Strong start to 2022 with bolstered Executive Team
DGAP-News: artnet AG: Strong start to 2022 with bolstered Executive Team
DGAP-News: artnet AG: Strong start to 2022 with bolstered Executive Team
 Biophytis received approval from ANVISA (Brazil) to give access to Sarconeos (BIO101) to hospitalized COVID-19 patients through an Expanded Access Program
Biophytis received approval from ANVISA (Brazil) to give access to Sarconeos (BIO101) to hospitalized COVID-19 patients through an Expanded Access Program
Biophytis received approval from ANVISA (Brazil) to give access to Sarconeos (BIO101) to hospitalized COVID-19 patients through an Expanded Access Program
Hardman & Co Research: Fidelity Japan Trust Plc - FJV: recent performance into perspective
Hardman & Co Research: Fidelity Japan Trust Plc - FJV: recent performance into perspective
Hardman & Co Research: Fidelity Japan Trust Plc - FJV: recent performance into perspective
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
DGAP-News: SFC Energy reaches agreement with Oneberry Technologies for delivery in two tranches of 150 EFOY fuel cells for civil security applications in Singapore
DGAP-News: SFC Energy reaches agreement with Oneberry Technologies for delivery in two tranches of 150 EFOY fuel cells for civil security applications in Singapore
DGAP-News: SFC Energy reaches agreement with Oneberry Technologies for delivery in two tranches of 150 EFOY fuel cells for civil security applications in Singapore
Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications
Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications
Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications
DGAP-News: Berentzen-Gruppe Aktiengesellschaft publishes preliminary operating results and outlook
DGAP-News: Berentzen-Gruppe Aktiengesellschaft publishes preliminary operating results and outlook
DGAP-News: Berentzen-Gruppe Aktiengesellschaft publishes preliminary operating results and outlook
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
Notification of managers' transactions
Notification of managers' transactions
Notification of managers' transactions